These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37288718)

  • 1. A Brief Guide to Preparing a Peptide-Drug Conjugate.
    Bugatti K
    Chembiochem; 2023 Sep; 24(17):e202300254. PubMed ID: 37288718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells.
    Kalimuthu K; Lubin BC; Bazylevich A; Gellerman G; Shpilberg O; Luboshits G; Firer MA
    J Nanobiotechnology; 2018 Mar; 16(1):34. PubMed ID: 29602308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide-drug conjugates: A new paradigm for targeted cancer therapy.
    Wang M; Liu J; Xia M; Yin L; Zhang L; Liu X; Cheng Y
    Eur J Med Chem; 2024 Feb; 265():116119. PubMed ID: 38194773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide-Drug Conjugate: A Novel Drug Design Approach.
    Ma L; Wang C; He Z; Cheng B; Zheng L; Huang K
    Curr Med Chem; 2017; 24(31):3373-3396. PubMed ID: 28393694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioanalytical workflow for novel scaffold protein-drug conjugates: quantitation of total Centyrin protein, conjugated Centyrin and free payload for Centyrin-drug conjugate in plasma and tissue samples using liquid chromatography-tandem mass spectrometry.
    Shi C; Goldberg S; Lin T; Dudkin V; Widdison W; Harris L; Wilhelm S; Jmeian Y; Davis D; O'Neil K; Weng N; Jian W
    Bioanalysis; 2018 Oct; 10(20):1651-1665. PubMed ID: 30372128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide cargo administration: current state and applications.
    Rohira H; Arora A; Kaur P; Chugh A
    Appl Microbiol Biotechnol; 2023 May; 107(10):3153-3181. PubMed ID: 37052636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxime-Linked Peptide-Daunomycin Conjugates as Good Tools for Selection of Suitable Homing Devices in Targeted Tumor Therapy: An Overview.
    Mező G; Gomena J; Ranđelović I; Dókus EL; Kiss K; Pethő L; Schuster S; Vári B; Vári-Mező D; Lajkó E; Polgár L; Kőhidai L; Tóvári J; Szabó I
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide-Drug Conjugates with Different Linkers for Cancer Therapy.
    Alas M; Saghaeidehkordi A; Kaur K
    J Med Chem; 2021 Jan; 64(1):216-232. PubMed ID: 33382619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering peptide drug therapeutics through chemical conjugation and implication in clinics.
    Rizvi SFA; Zhang H; Fang Q
    Med Res Rev; 2024 Nov; 44(6):2420-2471. PubMed ID: 38704826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymer-drug conjugates: recent advances and future perspectives.
    Thakor P; Bhavana V; Sharma R; Srivastava S; Singh SB; Mehra NK
    Drug Discov Today; 2020 Sep; 25(9):1718-1726. PubMed ID: 32629170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug conjugate-based anticancer therapy - Current status and perspectives.
    Yang Y; Wang S; Ma P; Jiang Y; Cheng K; Yu Y; Jiang N; Miao H; Tang Q; Liu F; Zha Y; Li N
    Cancer Lett; 2023 Jan; 552():215969. PubMed ID: 36279982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Antiplasmodial Peptide-Drug Conjugates Using a Human Protein-Derived Cell-Penetrating Peptide with Selectivity for Infected Cells.
    Palombi IR; Lawrence N; White AM; Gare CL; Craik DJ; McMorran BJ; Malins LR
    Bioconjug Chem; 2023 Jun; 34(6):1105-1113. PubMed ID: 37232456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of programmable gemcitabine-GnRH pro-drugs bearing linker controllable "click" oxime bond tethers and preclinical evaluation against prostate cancer.
    Vrettos EI; Karampelas T; Sayyad N; Kougioumtzi A; Syed N; Crook T; Murphy C; Tamvakopoulos C; Tzakos AG
    Eur J Med Chem; 2021 Feb; 211():113018. PubMed ID: 33223264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Efficient Approach for the Design and Synthesis of Antimicrobial Peptide-Peptide Nucleic Acid Conjugates.
    Patil NA; Thombare VJ; Li R; He X; Lu J; Yu HH; Wickremasinghe H; Pamulapati K; Azad MAK; Velkov T; Roberts KD; Li J
    Front Chem; 2022; 10():843163. PubMed ID: 35372270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide-drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?
    Fu C; Yu L; Miao Y; Liu X; Yu Z; Wei M
    Acta Pharm Sin B; 2023 Feb; 13(2):498-516. PubMed ID: 36873165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide-drug conjugate-based novel molecular drug delivery system in cancer.
    Zhu YS; Tang K; Lv J
    Trends Pharmacol Sci; 2021 Oct; 42(10):857-869. PubMed ID: 34334251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDCdb: the biological activity and pharmaceutical information of peptide-drug conjugate (PDC).
    Sun X; Li H; Chen Z; Zhang Y; Wei Z; Xu H; Liao Y; Jiang W; Ge Y; Zheng L; Li T; Wu Y; Luo M; Fang L; Dong X; Xiao M; Han L; Jia Q; Zhu F
    Nucleic Acids Res; 2024 Oct; ():. PubMed ID: 39360619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of Peptide-Drug Conjugates for Selective Targeting of Malignant Tumor Cells.
    Vrettos EI; Tzakos AG
    Methods Mol Biol; 2021; 2207():327-338. PubMed ID: 33113145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress and Future Directions with Peptide-Drug Conjugates for Targeted Cancer Therapy.
    Lindberg J; Nilvebrant J; Nygren PÅ; Lehmann F
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioconjugation in pharmaceutical chemistry.
    Veronese FM; Morpurgo M
    Farmaco; 1999 Aug; 54(8):497-516. PubMed ID: 10510847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.